| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 171.37B | 154.85B | 146.87B | 146.87B | 118.10B |
| Gross Profit | 113.59B | 106.04B | 102.63B | 105.12B | 88.58B |
| EBITDA | 31.87B | 32.03B | 17.00B | 15.97B | 20.36B |
| Net Income | 17.27B | 17.60B | 7.08B | 5.16B | 10.26B |
Balance Sheet | |||||
| Total Assets | 280.40B | 225.54B | 207.34B | 222.32B | 218.06B |
| Cash, Cash Equivalents and Short-Term Investments | 146.31B | 144.04B | 129.53B | 138.44B | 133.03B |
| Total Debt | 45.15B | 12.45B | 7.44B | 7.80B | 8.14B |
| Total Liabilities | 90.94B | 44.21B | 31.61B | 38.86B | 32.00B |
| Stockholders Equity | 182.39B | 180.06B | 174.52B | 182.14B | 184.64B |
Cash Flow | |||||
| Free Cash Flow | 10.43B | 23.77B | 9.76B | 18.88B | 731.00M |
| Operating Cash Flow | 20.23B | 30.26B | 13.22B | 20.85B | 4.04B |
| Investing Cash Flow | -31.55B | -14.49B | -6.85B | -7.35B | -17.44B |
| Financing Cash Flow | 13.22B | -10.38B | -15.73B | -8.33B | -16.63B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ¥175.87B | 9.72 | 10.05% | 4.61% | 10.67% | 1.68% | |
69 Neutral | ¥304.94B | 14.22 | 17.98% | 2.52% | -9.94% | -21.11% | |
66 Neutral | ¥44.42B | 6.92 | ― | 4.06% | 9.32% | 243.34% | |
61 Neutral | ¥131.06B | 19.38 | 3.38% | 2.38% | -5.49% | -82.16% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
54 Neutral | ¥72.72B | 23.27 | 1.59% | 2.09% | -8.43% | -5.44% | |
49 Neutral | ¥25.41B | -11.91 | ― | ― | -17.15% | -70.83% |